Search Results
Tuesday, May 24, 2022
Image
Participants of implanted neural device trials may have research-related care needs after the trial has ended. For example, these needs could include continued access to the device, device maintenance and support, explantation, and/or medical care resulting from participating in the research study. Discussions in the field suggest that…
The External Oversight Committee (EOC) of the Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) is an external advisory group of experts directed to provide independent advice to the NIH program staff and its current projects. The Committee currently consists of six members with an executive level of expertise in therapeutics discovery and pre-clinical development as well as comprehensive experience in effective portfolio analysis, planning and control, and decision-making process in both academia and industry.
As…
Friday, April 01, 2022
Image
NIH Program offers…
Thursday, May 05, 2022
Image
Date: May 5, 2022 | 12PM EDTRegistration
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics), which provides non-dilutive support for biotherapeutics discovery and development, from lead optimization through phase…
Thursday, May 05, 2022
Image
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics), which provides non-dilutive support for biologics neurotherapeutics discovery and development, from lead optimization through phase I clinical testing, held a Q&A Webinar for potential…
BPN-Biologics awardees receive no-cost access to the network's Contract Research Organizations (CROs). LDTs plan and coordinate studies conducted by BPN-Biologics CROs.
Current CROs for BPN-Biologics:
Biologics Consultants support the translational development of novel biologics through technical recommendations and advice to PI and her/his team. Consultants provide feedback and guidance on project milestones, development strategy, study design, and data interpretation. Each Lead Development Team (LDT) receives support from BPN-Biologics consultants. Consultants are assigned to a project with consideration of the project team's individual needs and consultants' expertise.
Current NIH-contracted Biologics Consultants…
Each Lead Development Team receives support from BPN consultants. Consultants are assigned to a project with considerations for the project team's individual needs and consultants' expertise.Paul Anderson, Ph.D., Medicinal chemistry Dr. Anderson is an independent pharmaceutical research consultant, specializing in medicinal chemistry. He has more than 25 years experience in drug discovery research and management, including more than 15 years in executive positions in large pharma and biotech.…
File
This is a preview of the Data Table. Only the first three rows are displayed.
Title
Disorder
PI/Lead Investigator
Institution
Developing nonmuscle II inhibitors for substance use…
To ensure the proper response to your inquiries, please fill out the Pre-submission Communication Form(pdf, 236 KB) and email it to BPN Biologics Questions.
Please provide all information requested in the form, along with the specific questions…